[1]宋稳鹏,白京岳,孟庆斌,等.血流导向装置与传统血管内重建治疗椎动脉夹层动脉瘤对比研究[J].介入放射学杂志,2022,31(06):545-549.
 SONG Wenpeng,BAI Jingyue,MENG Qingbin,et al.Flow diverter device versus traditional endovascular reconstruction for vertebral dissecting aneurysms: a comparative study[J].journal interventional radiology,2022,31(06):545-549.
点击复制

血流导向装置与传统血管内重建治疗椎动脉夹层动脉瘤对比研究()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
31
期数:
2022年06
页码:
545-549
栏目:
神经介入
出版日期:
2022-07-31

文章信息/Info

Title:
Flow diverter device versus traditional endovascular reconstruction for vertebral dissecting aneurysms: a comparative study
作者:
宋稳鹏 白京岳 孟庆斌 范 锋 管 生
Author(s):
SONG Wenpeng BAI Jingyue MENG Qingbin FAN Feng GUAN Sheng.
Department of Neurointervention, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province 450052, China
关键词:
【关键词】 颅内动脉瘤 椎动脉夹层 血流导向装置 血管内重建 疗效对比
文献标志码:
A
摘要:
 【摘要】 目的 探讨血流导向装置(FD)与传统血管内重建治疗椎动脉夹层动脉瘤(VADA)的安全性和有效性。 方法 回顾性分析2018年1月至2021年1月郑州大学第一附属医院采用介入手术治疗的72例VADA患者临床资料。其中男41例,女31例。根据治疗方式不同分为FD治疗组(n=25)和传统血管内治疗组(n=47)。对比分析两种术式治疗效果。结果 传统血管内治疗组瘤体破裂患者占比较多(P=0.043),FD治疗组患者年龄较小(P=0.041),动脉瘤长径较大(P=0.018)。两组患者随访(12.1±5.8)个月,范围为3~30个月。围手术期及随访结果显示,FD治疗、传统血管内治疗均能达到较高的动脉瘤闭塞率(83.3%比85.7%),疗效间差异无统计学意义(P=0.749)。FD治疗组围手术期及远期并发症发生率更低(0比10.6%)。结论 FD与传统血管内重建治疗VADA均安全有效,初步结果表明FD治疗后并发症及再治疗发生率较低、更安全。远期疗效有待多中心大规模研究进一步验证。

参考文献/References:

[1] Kapsalaki EZ, Rountas CD, Fountas KN. The role of 3 Tesla MRA in the detection of intracranial aneurysms[J]. Int J Vasc Med, 2012, 2012:792834
[2] 徐建国,朱巍巍,李 吻,等. 颅内椎动脉夹层动脉瘤血管内治疗策略及效果分析[J]. 中国脑血管病杂志, 2021, 18:115- 121.
[3] Zhang Y, Liang F, Zhang Y, et al. Exploring the feasibility of pipeline embolization device compared with stent- assisted coiling to treat non- saccular, unruptured, intradural vertebral artery aneurysms[J]. Front Neurol, 2019, 10: 275.
[4] 孙世蒙,李天晓,李 立,等. 国产Tubridge血流导向装置治疗椎动脉夹层动脉瘤的初步应用[J]. 中华介入放射学电子杂志, 2021, 9:160- 164.
[5] 王璐瑶,冯 欣,张宝瑞,等. LVIS及Enterprise两种支架辅助弹簧圈治疗椎动脉夹层动脉瘤的疗效分析[J]. 中华医学杂志, 2019, 99:685- 689.
[6] Zhao X, Wang H, Liu J, et al. Endovascular treatment of vertebral artery dissecting aneurysm: a single- center experience[J]. Exp Ther Med, 2019, 18: 4838- 4844.
[7] 张永智,史怀璋. 重叠支架技术与血流导向装置在椎动脉夹层动脉瘤中的应用[J]. 中国脑血管病杂志, 2020, 17:701- 706.
[8] Miao HL, Zhang DY, Wang T, et al. Clinical importance of the posterior inferior cerebellar artery: a review of the literature[J]. Int J Med Sci, 2020, 17:3005- 3019.
[9] Shi L, Xu K, Sun X, et al. Therapeutic progress in treating vertebral dissecting aneurysms involving the posterior inferior cerebellar artery[J]. Int J Med Sci, 2016, 13:540- 555.
[10] Suzuki S, Kurata A, Iwamoto K,et al. Endovascular surgery using stents for vertebral artery dissecting aneurysms and a review of the literature[J]. Minim Invasive Neurosurg, 2008, 51:193- 198.
[11] Adeeb N, Griessenauer CJ, Dmytriw AA, et al. Risk of branch occlusion and ischemic complications with the pipeline emboli-zation device in the treatment of posterior circulation aneurysms[J]. AJNR Am J Neuroradiol, 2018, 39:1303- 1309.
[12] Wang Y, Zhao C, Hao X, et al. Endovascular interventional therapy and classification of vertebral artery dissecting aneurysms[J]. Exp Ther Med, 2014, 8:1409- 1415.
[13] Lim YC, Shin YS, Chung J. Flow diversion via LVIS blue stent within enterprise stent in patients with vertebral artery dissecting aneurysm[J]. World Neurosurg, 2018, 117:203- 207.
[14] 何科君,李凡滢,梁 丰,等. 椎动脉夹层动脉瘤破裂危险因素与临床疗效[J]. 中国微侵袭神经外科杂志, 2020, 25:445- 449.
[15] 吴桥伟,李 立,邵秋季,等. Pipeline Flex血流导向装置治疗后循环大型动脉瘤单中心临床经验[J]. 介入放射学杂志, 2021, 30:434- 439.
[16] Liang F, Zhang Y, Yan P, et al. Outcomes and complications after the use of the pipeline embolization device in the treatment of intracranial aneurysms of the posterior circulation: a systematic review and meta- analysis[J]. World Neurosurg, 2019, 127: e888- e895.
[17] Griessenauer CJ, Ogilvy CS, Adeeb N, et al. Pipeline embolization of posterior circulation aneurysms: a multicenter study of 131 aneurysms[J]. J Neurosurg, 2018, 130: 923- 935.
[18] Luo B, Kang H, Zhang H, et al. Pipeline embolization device for intracranial aneurysms in a large Chinese cohort: factors related to aneurysm occlusion[J]. Ther Adv Neurol Disord, 2020, 13: 1756286420967828.
[19] Lylyk I, Scrivano E, Lundquist J, et al. Pipeline embolization devices for the treatment of intracranial aneurysms, single- center registry: long- term angiographic and clinical outcomes from 1000 aneurysms[J]. Neurosurgery, 2021, 89: 443- 449.

备注/Memo

备注/Memo:
(收稿日期:2021- 08- 22)
(本文编辑:边 佶)
更新日期/Last Update: 2022-07-27